Clinical Trials Directory

Trials / Completed

CompletedNCT02899039

Follicular Helper T Cells: Biological Marker and Involvement in the Physiopathology of the IgG4-related Disease

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
75 (actual)
Sponsor
Assistance Publique Hopitaux De Marseille · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

IgG4-related disease is a rare and very recently identified pathology, whose frequency is certainly underestimated. The clinical presentation varies among affected organs, and most often, patients have at least three organ damage. These organs exhibit tissue infiltration mononuclear polymorphic cells with often severe fibrosis progression resulting in a loss of function. The biomarker, though not specific, is a polyclonal elevated serum IgG4, and histological marker, currently held by several teams, is the presence within the inflammatory infiltrate, of a predominance of IgG4-expressing plasma-cells with a relative plasma-cells IgG4 + / IgG +\> 50% on tissue immunostaining. The investigators project provides a global assessment of T lymphocyte abnormalities and specifically the TFH (Follicular Helper) during this IgG4-related disease compared to so-called groups "control" subjects suffering from Sjogren syndrome or healthy subjects.

Conditions

Interventions

TypeNameDescription
BIOLOGICALextra blood draw samples

Timeline

Start date
2012-07-17
Primary completion
2015-05-04
Completion
2016-05-07
First posted
2016-09-13
Last updated
2023-07-28

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT02899039. Inclusion in this directory is not an endorsement.

Follicular Helper T Cells: Biological Marker and Involvement in the Physiopathology of the IgG4-related Disease (NCT02899039) · Clinical Trials Directory